… disease progression in the brain remain largely unknown. To better understand the pathological
… , and atrophy correlated with severity of brain Aβ pathology, tauopathy, and atrophy, and …

… a signature of cortical regions of interest preferentially affected by Alzheimer disease (AD)
pathology … Since late-onset Alzheimer disease (LOAD) participants tend to have age-related …

… We identified hypometabolism signatures for each clinical atypical variant within the AD …
paradigm of neurodegenerative disease, positing that the pathology associated with these …

… Alzheimer disease (AD) diagnosis. Our results indicate that the serum microRNA signature
… Alzheimer disease (AD) 6 is the most common form of dementia with increasing prevalence …

… consistent with very early AD pathology could be detected in … ) collectively called the cortical
signature of AD based on our … Figure 3 Alzheimer disease (AD)-signature MRI biomarker …

… signature. In steps 3 and 4, we tested associations between the incipient AD proteomic
signature and both AD pathology … pathology. In step 6b, we validated the incipient AD proteomic …

… We present early evidence for unique pathological signatures of gait in AD and LBD from …
findings provide initial evidence that Alzheimer's disease and Lewy body disease have unique …

… Several studies suggest that pathological changes in Alzheimer’s disease (AD) brain begin
around 10–20 years before the onset of cognitive impairment. Biomarkers that can support …

… 34,36 to understand the effect of multiple genomic signatures of aging on clinical and pathologic
features of AD, other neurodegenerative diseases, and cerebrovascular disease (CVD). …

… , and also thioflavin-S-negative pathology in corticobasal degeneration and progressive …
of Alzheimer's disease pathology, but was more prominently associated with pathological tau …